Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

A Key Role for the Ubiquitin Ligase UBR4 in Myofiber Hypertrophy in Drosophila and Mice.

Hunt LC, Stover J, Haugen B, Shaw TI, Li Y, Pagala VR, Finkelstein D, Barton ER, Fan Y, Labelle M, Peng J, Demontis F.

Cell Rep. 2019 Jul 30;28(5):1268-1281.e6. doi: 10.1016/j.celrep.2019.06.094.

2.

Functional muscle hypertrophy by increased insulin-like growth factor 1 does not require dysferlin.

Barton ER, Pham J, Brisson BK, Park S, Smith LR, Liu M, Tian Z, Hammers DW, Vassilakos G, Sweeney HL.

Muscle Nerve. 2019 Oct;60(4):464-473. doi: 10.1002/mus.26641. Epub 2019 Jul 30.

3.

Smooth muscle atrophy and colon pathology in SMN deficient mice.

Yang Y, Vassilakos G, Hammers DW, Yang Z, Barton ER, Sweeney HL.

Am J Transl Res. 2019 Mar 15;11(3):1789-1799. eCollection 2019.

4.

Deleting nebulin's C-terminus reveals its importance to sarcomeric structure and function and is sufficient to invoke nemaline myopathy.

Li F, Barton ER, Granzier H.

Hum Mol Genet. 2019 May 15;28(10):1709-1725. doi: 10.1093/hmg/ddz016.

PMID:
30689900
5.

Insulin-Like Growth Factor I Regulation and Its Actions in Skeletal Muscle.

Vassilakos G, Barton ER.

Compr Physiol. 2018 Dec 13;9(1):413-438. doi: 10.1002/cphy.c180010. Review.

PMID:
30549022
6.

Generation and characterization of monoclonal antibodies that recognize human and murine supervillin protein isoforms.

Smith TC, Saul RG, Barton ER, Luna EJ.

PLoS One. 2018 Oct 17;13(10):e0205910. doi: 10.1371/journal.pone.0205910. eCollection 2018.

7.

Deletion of muscle IGF-I transiently impairs growth and progressively disrupts glucose homeostasis in male mice.

Vassilakos G, Lei H, Yang Y, Puglise J, Matheny M, Durzynska J, Ozery M, Bennett K, Spradlin R, Bonanno H, Park S, Ahima RS, Barton ER.

FASEB J. 2019 Jan;33(1):181-194. doi: 10.1096/fj.201800459R. Epub 2018 Jun 22.

PMID:
29932867
8.

Regulation of fibrosis in muscular dystrophy.

Smith LR, Barton ER.

Matrix Biol. 2018 Aug;68-69:602-615. doi: 10.1016/j.matbio.2018.01.014. Epub 2018 Feb 2. Review.

9.

Contrast-Enhanced Near-Infrared Optical Imaging Detects Exacerbation and Amelioration of Murine Muscular Dystrophy.

Chrzanowski SM, Vohra RS, Lee-McMullen BA, Batra A, Spradlin RA, Morales J, Forbes S, Vandenborne K, Barton ER, Walter GA.

Mol Imaging. 2017 Jan-Dec;16:1536012117732439. doi: 10.1177/1536012117732439.

10.

A shared data approach more accurately represents the rates and patterns of violence with injury assaults.

Gray BJ, Barton ER, Davies AR, Long SJ, Roderick J, Bellis MA.

J Epidemiol Community Health. 2017 Dec;71(12):1218-1224. doi: 10.1136/jech-2017-209872. Epub 2017 Oct 22.

11.

The IGF axis in HPV associated cancers.

Pickard A, Durzynska J, McCance DJ, Barton ER.

Mutat Res Rev Mutat Res. 2017 Apr - Jun;772:67-77. doi: 10.1016/j.mrrev.2017.01.002. Epub 2017 Feb 4. Review.

PMID:
28528691
12.

Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy.

Liu M, Hammers DW, Barton ER, Sweeney HL.

PLoS One. 2016 Nov 21;11(11):e0166803. doi: 10.1371/journal.pone.0166803. eCollection 2016.

13.

Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype.

Capote J, Kramerova I, Martinez L, Vetrone S, Barton ER, Sweeney HL, Miceli MC, Spencer MJ.

J Cell Biol. 2016 Apr 25;213(2):275-88. doi: 10.1083/jcb.201510086. Epub 2016 Apr 18.

14.

South Carolina 20 Years of Diabetes--A Public Health Concern.

Heidari K, Breneman CB, Barton ER, Fogner A, Callahan K, Diedhiou A.

Am J Med Sci. 2016 Apr;351(4):327-32. doi: 10.1016/j.amjms.2016.01.006.

PMID:
27079337
15.

Increased collagen cross-linking is a signature of dystrophin-deficient muscle.

Smith LR, Hammers DW, Sweeney HL, Barton ER.

Muscle Nerve. 2016 Jun;54(1):71-8. doi: 10.1002/mus.24998. Epub 2016 Feb 22.

16.

Role of IGF-I signaling in muscle bone interactions.

Bikle DD, Tahimic C, Chang W, Wang Y, Philippou A, Barton ER.

Bone. 2015 Nov;80:79-88. doi: 10.1016/j.bone.2015.04.036. Review.

17.

Muscle hypertrophy induced by myostatin inhibition accelerates degeneration in dysferlinopathy.

Lee YS, Lehar A, Sebald S, Liu M, Swaggart KA, Talbot CC Jr, Pytel P, Barton ER, McNally EM, Lee SJ.

Hum Mol Genet. 2015 Oct 15;24(20):5711-9. doi: 10.1093/hmg/ddv288. Epub 2015 Jul 23.

18.

Selective Retinoic Acid Receptor γ Agonists Promote Repair of Injured Skeletal Muscle in Mouse.

Di Rocco A, Uchibe K, Larmour C, Berger R, Liu M, Barton ER, Iwamoto M.

Am J Pathol. 2015 Sep;185(9):2495-504. doi: 10.1016/j.ajpath.2015.05.007. Epub 2015 Jul 21.

19.

Masticatory muscles of mouse do not undergo atrophy in space.

Philippou A, Minozzo FC, Spinazzola JM, Smith LR, Lei H, Rassier DE, Barton ER.

FASEB J. 2015 Jul;29(7):2769-79. doi: 10.1096/fj.14-267336. Epub 2015 Mar 20.

20.

Gamma-sarcoglycan is required for the response of archvillin to mechanical stimulation in skeletal muscle.

Spinazzola JM, Smith TC, Liu M, Luna EJ, Barton ER.

Hum Mol Genet. 2015 May 1;24(9):2470-81. doi: 10.1093/hmg/ddv008. Epub 2015 Jan 20.

21.

Targeting latent TGFβ release in muscular dystrophy.

Ceco E, Bogdanovich S, Gardner B, Miller T, DeJesus A, Earley JU, Hadhazy M, Smith LR, Barton ER, Molkentin JD, McNally EM.

Sci Transl Med. 2014 Oct 22;6(259):259ra144. doi: 10.1126/scitranslmed.3010018.

22.

Whole body periodic acceleration is an effective therapy to ameliorate muscular dystrophy in mdx mice.

Altamirano F, Perez CF, Liu M, Widrick J, Barton ER, Allen PD, Adams JA, Lopez JR.

PLoS One. 2014 Sep 2;9(9):e106590. doi: 10.1371/journal.pone.0106590. eCollection 2014.

23.

Absence of γ-sarcoglycan alters the response of p70S6 kinase to mechanical perturbation in murine skeletal muscle.

Moorwood C, Philippou A, Spinazzola J, Keyser B, Macarak EJ, Barton ER.

Skelet Muscle. 2014 Jul 1;4:13. doi: 10.1186/2044-5040-4-13. eCollection 2014.

24.

Optimizing IGF-I for skeletal muscle therapeutics.

Philippou A, Barton ER.

Growth Horm IGF Res. 2014 Oct;24(5):157-63. doi: 10.1016/j.ghir.2014.06.003. Epub 2014 Jun 19. Review.

25.

Caspase-12 ablation preserves muscle function in the mdx mouse.

Moorwood C, Barton ER.

Hum Mol Genet. 2014 Oct 15;23(20):5325-41. doi: 10.1093/hmg/ddu249. Epub 2014 May 30.

26.

Collagen content does not alter the passive mechanical properties of fibrotic skeletal muscle in mdx mice.

Smith LR, Barton ER.

Am J Physiol Cell Physiol. 2014 May 15;306(10):C889-98. doi: 10.1152/ajpcell.00383.2013. Epub 2014 Mar 5.

27.

Gene transfer of arginine kinase to skeletal muscle using adeno-associated virus.

Forbes SC, Bish LT, Ye F, Spinazzola J, Baligand C, Plant D, Vandenborne K, Barton ER, Sweeney HL, Walter GA.

Gene Ther. 2014 Apr;21(4):387-92. doi: 10.1038/gt.2014.9. Epub 2014 Feb 27.

28.

Viral expression of insulin-like growth factor I E-peptides increases skeletal muscle mass but at the expense of strength.

Brisson BK, Spinazzola J, Park S, Barton ER.

Am J Physiol Endocrinol Metab. 2014 Apr 15;306(8):E965-74. doi: 10.1152/ajpendo.00008.2014. Epub 2014 Feb 25.

29.

SMASH - semi-automatic muscle analysis using segmentation of histology: a MATLAB application.

Smith LR, Barton ER.

Skelet Muscle. 2014 Nov 27;4:21. doi: 10.1186/2044-5040-4-21. eCollection 2014.

30.

Mature IGF-I excels in promoting functional muscle recovery from disuse atrophy compared with pro-IGF-IA.

Park S, Brisson BK, Liu M, Spinazzola JM, Barton ER.

J Appl Physiol (1985). 2014 Apr 1;116(7):797-806. doi: 10.1152/japplphysiol.00955.2013. Epub 2013 Dec 26.

31.

Recessive and dominant mutations in COL12A1 cause a novel EDS/myopathy overlap syndrome in humans and mice.

Zou Y, Zwolanek D, Izu Y, Gandhy S, Schreiber G, Brockmann K, Devoto M, Tian Z, Hu Y, Veit G, Meier M, Stetefeld J, Hicks D, Straub V, Voermans NC, Birk DE, Barton ER, Koch M, Bönnemann CG.

Hum Mol Genet. 2014 May 1;23(9):2339-52. doi: 10.1093/hmg/ddt627. Epub 2013 Dec 11.

32.

A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species.

Xu C, Tabebordbar M, Iovino S, Ciarlo C, Liu J, Castiglioni A, Price E, Liu M, Barton ER, Kahn CR, Wagers AJ, Zon LI.

Cell. 2013 Nov 7;155(4):909-921. doi: 10.1016/j.cell.2013.10.023.

33.

Long-term wheel running compromises diaphragm function but improves cardiac and plantarflexor function in the mdx mouse.

Selsby JT, Acosta P, Sleeper MM, Barton ER, Sweeney HL.

J Appl Physiol (1985). 2013 Sep 1;115(5):660-6. doi: 10.1152/japplphysiol.00252.2013. Epub 2013 Jul 3.

34.

Matrix metalloproteinase 13 is a new contributor to skeletal muscle regeneration and critical for myoblast migration.

Lei H, Leong D, Smith LR, Barton ER.

Am J Physiol Cell Physiol. 2013 Sep;305(5):C529-38. doi: 10.1152/ajpcell.00051.2013. Epub 2013 Jun 12.

35.

New Modulators for IGF-I Activity within IGF-I Processing Products.

Brisson BK, Barton ER.

Front Endocrinol (Lausanne). 2013 Mar 27;4:42. doi: 10.3389/fendo.2013.00042. eCollection 2013.

36.

The pro-forms of insulin-like growth factor I (IGF-I) are predominant in skeletal muscle and alter IGF-I receptor activation.

Durzyńska J, Philippou A, Brisson BK, Nguyen-McCarty M, Barton ER.

Endocrinology. 2013 Mar;154(3):1215-24. doi: 10.1210/en.2012-1992. Epub 2013 Feb 13.

37.

Isometric and eccentric force generation assessment of skeletal muscles isolated from murine models of muscular dystrophies.

Moorwood C, Liu M, Tian Z, Barton ER.

J Vis Exp. 2013 Jan 31;(71):e50036. doi: 10.3791/50036.

38.

Human Eb peptide: not just a by-product of pre-pro-IGF1b processing?

Durzyńska J, Wardziński A, Koczorowska M, Goździcka-Józefiak A, Barton ER.

Horm Metab Res. 2013 Jun;45(6):415-22. doi: 10.1055/s-0032-1331699. Epub 2013 Jan 18.

39.

Insulin-like growth factor-I E-peptide activity is dependent on the IGF-I receptor.

Brisson BK, Barton ER.

PLoS One. 2012;7(9):e45588. doi: 10.1371/journal.pone.0045588. Epub 2012 Sep 21.

40.

HEXIM1 controls satellite cell expansion after injury to regulate skeletal muscle regeneration.

Hong P, Chen K, Huang B, Liu M, Cui M, Rozenberg I, Chaqour B, Pan X, Barton ER, Jiang XC, Siddiqui MA.

J Clin Invest. 2012 Nov;122(11):3873-87.

41.

Deletion of muscle GRP94 impairs both muscle and body growth by inhibiting local IGF production.

Barton ER, Park S, James JK, Makarewich CA, Philippou A, Eletto D, Lei H, Brisson B, Ostrovsky O, Li Z, Argon Y.

FASEB J. 2012 Sep;26(9):3691-702. doi: 10.1096/fj.11-203026. Epub 2012 May 30.

42.

Rescue of dystrophic skeletal muscle by PGC-1α involves a fast to slow fiber type shift in the mdx mouse.

Selsby JT, Morine KJ, Pendrak K, Barton ER, Sweeney HL.

PLoS One. 2012;7(1):e30063. doi: 10.1371/journal.pone.0030063. Epub 2012 Jan 11.

43.

Is functional hypertrophy and specific force coupled with the addition of myonuclei at the single muscle fiber level?

Qaisar R, Renaud G, Morine K, Barton ER, Sweeney HL, Larsson L.

FASEB J. 2012 Mar;26(3):1077-85. doi: 10.1096/fj.11-192195. Epub 2011 Nov 28.

44.

Chronic losartan administration reduces mortality and preserves cardiac but not skeletal muscle function in dystrophic mice.

Bish LT, Yarchoan M, Sleeper MM, Gazzara JA, Morine KJ, Acosta P, Barton ER, Sweeney HL.

PLoS One. 2011;6(6):e20856. doi: 10.1371/journal.pone.0020856. Epub 2011 Jun 22.

45.

The role of GH and IGF-I in mediating anabolic effects of testosterone on androgen-responsive muscle.

Serra C, Bhasin S, Tangherlini F, Barton ER, Ganno M, Zhang A, Shansky J, Vandenburgh HH, Travison TG, Jasuja R, Morris C.

Endocrinology. 2011 Jan;152(1):193-206. doi: 10.1210/en.2010-0802. Epub 2010 Nov 17.

46.

IGF-I and vitamin C promote myogenic differentiation of mouse and human skeletal muscle cells at low temperatures.

Shima A, Pham J, Blanco E, Barton ER, Sweeney HL, Matsuda R.

Exp Cell Res. 2011 Feb 1;317(3):356-66. doi: 10.1016/j.yexcr.2010.11.001. Epub 2010 Nov 9.

PMID:
21070767
47.

Regulation of muscle mass by follistatin and activins.

Lee SJ, Lee YS, Zimmers TA, Soleimani A, Matzuk MM, Tsuchida K, Cohn RD, Barton ER.

Mol Endocrinol. 2010 Oct;24(10):1998-2008. doi: 10.1210/me.2010-0127. Epub 2010 Sep 1.

48.

Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy.

Morine KJ, Bish LT, Selsby JT, Gazzara JA, Pendrak K, Sleeper MM, Barton ER, Lee SJ, Sweeney HL.

Muscle Nerve. 2010 Nov;42(5):722-30. doi: 10.1002/mus.21743.

49.

Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppression.

Wang B, Yang Z, Brisson BK, Feng H, Zhang Z, Welch EM, Peltz SW, Barton ER, Brown RH Jr, Sweeney HL.

J Appl Physiol (1985). 2010 Sep;109(3):901-5. doi: 10.1152/japplphysiol.01366.2009. Epub 2010 Jun 17.

50.

Diaphragm displays early and progressive functional deficits in dysferlin-deficient mice.

Barton ER, Wang BJ, Brisson BK, Sweeney HL.

Muscle Nerve. 2010 Jul;42(1):22-9. doi: 10.1002/mus.21645.

Supplemental Content

Loading ...
Support Center